NuPathe drops Endo deal for Teva bid
January 21, 2014 at 08:11 AM EST
NuPathe Inc. scrapped its merger pact with Endo Health Solutions in favor of a $144 million bid from Teva Pharmaceuticals, potentially giving the small drug developer the support it needs to launch its Zecuity migraine treatment.
